ArriVent BioPharma, Inc. (AVBP)
NASDAQ: AVBP · Real-Time Price · USD
21.89
+0.34 (1.58%)
Jul 22, 2025, 3:44 PM - Market open

ArriVent BioPharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '25 Dec '24 Dec '23 Dec '22 Dec '21
800898---
Enterprise Value
616615---
Last Close Price
21.5526.64---
PB Ratio
3.623.48---
P/TBV Ratio
3.913.48---
Debt / Equity Ratio
0.000.000.000.00-
Quick Ratio
13.6312.7013.0019.6020.64
Current Ratio
14.3413.1413.7621.8523.63
Return on Equity (ROE)
-49.00%-39.36%-42.57%-34.22%-
Return on Assets (ROA)
-23.10%-26.91%-26.95%-20.42%-
Return on Capital (ROIC)
-24.10%-28.79%-28.58%-21.38%-
Earnings Yield
-16.10%-8.97%---
Buyback Yield / Dilution
-316.83%-1369.88%-67.64%-79.57%-
Updated May 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q